Satoshi Umemura Selected Research

Satoshi Umemura Research Topics

Disease

47	Hypertension (High Blood Pressure) 11/2019 - 01/2002
25	Heart Failure 10/2017 - 03/2002
21	Acute Coronary Syndrome 07/2017 - 06/2004
21	Myocardial Infarction 01/2017 - 08/2002
18	Chronic Renal Insufficiency 10/2017 - 09/2003
14	Coronary Artery Disease (Coronary Atherosclerosis) 06/2016 - 01/2004
12	Fibrosis (Cirrhosis) 08/2018 - 11/2007
9	Proteinuria 05/2014 - 09/2003
9	Essential Hypertension 03/2013 - 02/2002
8	Cardiomegaly (Heart Hypertrophy) 08/2013 - 05/2003
7	Body Weight (Weight, Body) 10/2017 - 09/2003
7	Cardiovascular Diseases (Cardiovascular Disease) 07/2017 - 08/2003
7	Insulin Resistance 03/2017 - 08/2004
7	Infarction (Infarctions) 01/2017 - 01/2005
6	Hypertrophy 08/2018 - 03/2005
6	Albuminuria 06/2017 - 08/2005
6	ST Elevation Myocardial Infarction 11/2016 - 05/2010
6	Diabetic Nephropathies (Diabetic Nephropathy) 12/2012 - 01/2004
5	Inflammation (Inflammations) 03/2017 - 12/2006
5	Diabetes Mellitus 02/2017 - 09/2006
5	Atherosclerosis 11/2016 - 11/2007
5	Type 2 Diabetes Mellitus (MODY) 06/2016 - 08/2004
5	Shock 01/2014 - 04/2006
5	Rupture 11/2012 - 06/2004
4	Ischemia 05/2017 - 08/2003
4	Abdominal Obesity 03/2017 - 01/2013
4	Hemorrhage 01/2017 - 06/2009
4	Coronary Occlusion 02/2016 - 07/2006
4	Atrial Fibrillation 01/2012 - 04/2002
3	Thrombosis (Thrombus) 05/2017 - 11/2012
3	Obesity 03/2017 - 01/2013
3	Dyslipidemias (Dyslipidemia) 01/2017 - 04/2013
3	Pathologic Constriction (Stenosis) 01/2016 - 04/2011
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2013 - 12/2003
3	Renal Insufficiency (Renal Failure) 12/2012 - 02/2002
3	Tachycardia (Tachyarrhythmias) 01/2010 - 11/2002
3	Neoplasms (Cancer) 02/2007 - 10/2003
3	Ventricular Fibrillation 07/2006 - 11/2003
2	Ureteral Obstruction 06/2017 - 06/2013
2	Cerebral Infarction 05/2017 - 08/2004

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 06/2017 - 03/2003
16	Angiotensin IIIBA 06/2017 - 06/2004
15	Glucose (Dextrose)FDA LinkGeneric 03/2017 - 03/2002
11	Antihypertensive Agents (Antihypertensives)IBA 11/2019 - 01/2002
11	Angiotensin Receptor AntagonistsIBA 01/2016 - 09/2003
11	CreatinineIBA 01/2014 - 02/2002
9	Type 1 Angiotensin ReceptorIBA 03/2017 - 03/2005
8	SodiumIBA 10/2017 - 01/2006
8	LipidsIBA 11/2016 - 01/2004
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2016 - 07/2004
7	AngiotensinogenIBA 08/2018 - 08/2003
7	Amlodipine (Norvasc)FDA LinkGeneric 01/2016 - 09/2003
7	olmesartanIBA 10/2014 - 10/2008
6	CalciumIBA 02/2018 - 01/2007
6	Messenger RNA (mRNA)IBA 06/2017 - 02/2007
6	Protein Isoforms (Isoforms)IBA 06/2017 - 05/2003
6	SaltsIBA 01/2016 - 01/2006
6	oxidized low density lipoproteinIBA 12/2015 - 03/2003
6	Losartan (Cozaar)FDA LinkGeneric 01/2014 - 09/2003
6	candesartanIBA 01/2012 - 03/2003
5	aliskiren FDA Link 08/2018 - 01/2012
5	CholesterolIBA 01/2017 - 03/2003
5	Therapeutic UsesIBA 01/2016 - 10/2011
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2014 - 09/2003
5	AlbuminsIBA 01/2014 - 02/2002
5	C-Reactive ProteinIBA 10/2011 - 10/2006
4	DiureticsIBA 10/2017 - 01/2014
4	Irbesartan FDA LinkGeneric 01/2016 - 10/2012
4	ReninIBA 07/2014 - 01/2012
4	Clopidogrel (Plavix)FDA Link 09/2013 - 06/2009
4	Valsartan (Vals)FDA Link 03/2013 - 05/2009
4	Troponin T (Troponin T1)IBA 01/2013 - 06/2005
4	Insulin (Novolin)FDA Link 04/2011 - 01/2004
3	Parathyroid Hormone (Parathormone)IBA 09/2018 - 01/2007
3	AdipokinesIBA 03/2017 - 11/2007
3	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2016 - 01/2006
3	Epithelial Sodium ChannelsIBA 01/2016 - 01/2012
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016 - 10/2014
3	Blood Glucose (Blood Sugar)IBA 08/2015 - 01/2005
3	LDL CholesterolIBA 09/2013 - 10/2012
3	AngiotensinsIBA 08/2013 - 01/2012
3	LDL Lipoproteins (beta Lipoproteins)IBA 04/2013 - 03/2003
3	Angiotensin II Type 1 Receptor BlockersIBA 03/2013 - 03/2003
3	Biomarkers (Surrogate Marker)IBA 01/2013 - 08/2011
3	Creatine Kinase (Creatine Phosphokinase)IBA 05/2010 - 01/2005
3	AdiponectinIBA 04/2009 - 09/2006
2	Renin InhibitorsIBA 08/2018 - 01/2016
2	Nitric Oxide Synthase (NO Synthase)IBA 02/2018 - 07/2014
2	Heparin (Liquaemin)FDA LinkGeneric 05/2017 - 02/2012
2	Indicators and Reagents (Reagents)IBA 02/2017 - 01/2015

Therapy/Procedure

37	Therapeutics 11/2019 - 06/2002
11	Percutaneous Coronary Intervention 01/2017 - 03/2003
9	Cardiac Resynchronization Therapy 10/2012 - 03/2002
8	Renal Dialysis (Hemodialysis) 01/2014 - 06/2002
5	Stents 05/2017 - 09/2004
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2017 - 01/2005
3	Blood Component Removal (Apheresis) 04/2013 - 03/2003
3	Continuous Ambulatory Peritoneal Dialysis (CAPD) 10/2008 - 06/2002
2	Patient Readmission 07/2017 - 01/2017
2	Nephrectomy 06/2017 - 01/2017